---
schema_version: "secwatch.filing_event.v1"
accession: "0001562762-22-000242"
form_type: "8-K"
ticker: "GMED"
cik: "0001237831"
company_name: "GLOBUS MEDICAL INC"
filed_at: "2022-05-10T23:59:59+00:00"
generated_at: "2026-06-25T21:29:09.635218+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Globus Medical Q1 2022 net sales $230.5M, up 1.4% YoY; GAAP EPS $0.37, non-GAAP $0.42

## Summary
- Net sales $230.5M, up 1.4% YoY (1.9% constant currency); U.S. spine sales recovered in March.
- GAAP net income $38.1M (-16% YoY); GAAP diluted EPS $0.37 vs $0.44 in Q1 2021.
- Non-GAAP diluted EPS $0.42 vs $0.49 in Q1 2021, down 13.1% on higher product development and sales costs.
- FY 2022 guidance reaffirmed: net sales $1.025B, non-GAAP diluted EPS $2.10.
- First Excelsius3D imaging units shipped; Enabling Technologies pipeline strong.

## SEC filing metadata
- accession: 0001562762-22-000242
- form_type: 8-K
- ticker: GMED
- cik: 0001237831
- company_name: GLOBUS MEDICAL INC
- filed_at: 2022-05-10T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1237831/000156276222000242/0001562762-22-000242-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1237831/000156276222000242/gmed-20220510x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001562762-22-000242
- JSON: https://secwatch.observer/filing/0001562762-22-000242.json
- Plain text: https://secwatch.observer/filing/0001562762-22-000242.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.